Nitin Bhatti

Sanctions API Use Case Scenarios and usage with Agent based Supply Chain and Fintech Services

by•

Hey Product Hunt! 👋

I'm Nitin, founder of OrchestraPrime. We built SanctionsWise to solve

a problem that spans multiple industries: sanctions screening without

enterprise complexity.

The Problem:

Whether you're a fintech doing KYC or a pharma company screening clinical

trial suppliers, you need sanctions screening. But your options are:

- Enterprise platforms ($50k+/year, months to integrate)

- Basic APIs with exact-match only (miss name variations)

- "Contact sales" black-box pricing

What We Built:

SanctionsWise is a REST API that:

- Screens in under 100ms

- Uses ML-powered fuzzy matching (99.2% accuracy)

- Costs $0.005/check with no minimums

- Covers OFAC, BIS, UN, EU, and UK sanctions lists

- Integrates with any ERP/procurement system via simple REST calls

Use Cases We're Seeing:

1. Fintechs - KYC/AML customer screening

2. Crypto/DeFi - Transaction and wallet compliance

3. Pharma/Life Sciences - Clinical supply chain vendor screening

4. Trade Finance - Counterparty screening

Technical Details:

- OpenAPI 3.0 compliant (easy integration)

- API key authentication

- Batch screening (up to 100 entities)

- Webhook support for continuous monitoring

Free Trial:

14 days, 1,000 screenings on AWS Marketplace.

Would love feedback from anyone building compliance into their products!

🔗 Try it: [AWS Marketplace link]

📖 Docs: [Documentation link]

3 views

Add a comment

Replies

Best
Nitin Bhatti

For folks associated to Oracle's AI Agent Martetplace, here is another way to think about this product offerings:

  1. First-Mover Advantage - Oracle's AI Agent Marketplace launched in October 2025, and there's no dedicated sanctions screening ISV on the platform yet.

  2. Clear Pain Point - Oracle customers are actively asking "How do we do OFAC screening for suppliers?" (Oracle Community thread). Current solutions are legacy integrations, not AI Agent Studio native.

  3. Clinical Supply Chain = High Compliance Risk - Pharma companies face dual compliance requirements: trade sanctions (OFAC, BIS) AND regulatory requirements (FDA, ICH).Â